Filing Details
- Accession Number:
- 0001209191-14-070491
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-11-20 20:33:33
- Reporting Period:
- 2014-11-18
- Filing Date:
- 2014-11-20
- Accepted Time:
- 2014-11-20 20:33:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1479290 | Revance Therapeutics Inc. | RVNC | Pharmaceutical Preparations (2834) | 770551645 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1597578 | Curtis Ruegg | C/O Revance Therapeutics, Inc. 7555 Gateway Boulevard Newark CA 94560 | Evp R&D And Tech Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-11-18 | 1,000 | $2.55 | 15,106 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-11-18 | 1,000 | $16.00 | 14,106 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2014-11-18 | 1,000 | $0.00 | 1,000 | $2.55 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1,504 | 2020-07-20 | No | 4 | M | Direct |
Footnotes
- 838 shares acquired by the Reporting Person under the Issuer Employee Stock Purchase Plan were inadvertently omitted in Column 5 of the Reporting Person's Form 4 filed on September 19, 2014, and were also omitted from two subsequent Forms 4 filed by the Reporting Person on October 17, 2014 and October 30, 2014. The share amount reflects the total shares owned after all transactions that occurred on September 17, 2014 through October 28, 2014, i.e. as of October 28, 2014, the Reporting Person owned a total of 14,106 shares.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 15, 2014.
- The Option is fully vested as of January 1, 2014.
Billionaire Hedge Funds
